[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pelvic-congestion-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pelvic-congestion-syndrome":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,66],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100649485","endovascular-management-of-pelvic-congestion-syndrome-100649485",false,"NCT07735156","Endovascular Management of Pelvic Congestion Syndrome","Role of Endovascular Management of Pelvic Congestion Syndome","PCSIR","Inclusion Criteria:\n\n* Female patients aged 18 years or older.\n* Chronic pelvic pain for more than 6 months.\n* Clinical suspicion of pelvic congestion syndrome.\n* Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography.\n* Patients willing to undergo endovascular embolization.\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* Pregnancy.\n* Active pelvic inflammatory disease.\n* Known pelvic malignancy.\n* Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids).\n* Contraindication to iodinated contrast media.\n* Severe renal impairment.\n* Uncorrectable coagulation disorders.\n* Refusal to participate.","FEMALE","17 Years","55 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS",[28],"Pelvic Congestion Syndrome","RECRUITING","2026-07-26",{"date":32,"type":33},"2026-07-29","ACTUAL",{"date":35,"type":33},"2026-01-14",{"date":37,"type":22},"2027-06-20",{"name":39,"class":40},"Sohag University","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":4},"100629271","embolization-of-ovarian-vein-and-pelvic-venous-reservoir-for-treatment-of-secondary-pelvic-congestion-syndrome-100629271","NCT07472504","Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Secondary Pelvic Congestion Syndrome","Transcatheter Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Pelvic Congestion Syndrome Secondary to May-Thurner Syndrome.","Inclusion Criteria:\n\n* • Adult females aged 18 -60 years.\n\n  * Clinical symptoms consistent with PCS \\>6 months refractory to conservative treatment(e.g., chronic pelvic pain (CPP) of at least 6 months duration, unresponsive to conventional pain management strategies and worsening with standing, dyspareunia, pelvic heaviness, presence of vulvar\u002Fperineal\u002Fthigh varices and ovarian point tenderness during examination in patients with history of post-coital pain).\n  * Symptom Correlation: Pelvic pain is deemed to be significantly attributable to the identified iliac venous compression after multidisciplinary assessment for exclusion of the other causes of chronic pelvic pain (e.g., gynaecologist, urologist, pain specialist).\n  * Imaging-confirmed non-thrombotic iliac venous outflow stenosis or occlusion with ovarian and\u002For pelvic venous reservoir reflux (e.g., cross-sectional area reduction on direct CT venography, MR venography or digital subtraction angiography)\n  * Informed Consent: Willingness and ability to provide written informed consent prior to study-specific procedures.\n  * Adherence to Follow-up: Willingness and ability to comply with scheduled follow-up visits and study procedures.\n\nExclusion Criteria:\n\n* Primary Pelvic Congestion Syndrome (PCS) only: Patients with significant pelvic venous reflux (e.g., ovarian or internal iliac vein reflux) without demonstrable and significant iliac venous outflow obstruction (i.e., primary PCS without secondary component).\n* Pelvic Congestion Syndrome secondary to Nutcracker syndrome.\n* Acute Deep Vein Thrombosis (DVT) on the affected side or known uncontrolled hypercoagulable states.\n* Contraindications to Anticoagulation: Known severe coagulopathy or absolute contraindications to the required antiplatelet and\u002For anticoagulant therapy post-stenting.\n* Pregnancy.\n* Severe Systemic Illness: Patients with severe, uncontrolled systemic diseases (e.g., severe renal failure, uncontrolled heart failure, uncontrolled hypertension, severe liver dysfunction) that would preclude safe participation in an invasive procedure or confound symptom assessment.\n* Active Infection: Any active systemic or localized infection, particularly at the access site.\n* Malignancy: Known active malignancy, especially pelvic malignancy, which could be the primary cause of pelvic pain or venous compression.\n* Other Dominant Causes of Pelvic Pain: Clear evidence of other treatable and dominant causes of chronic pelvic pain (e.g., severe endometriosis, adenomyosis, large uterine fibroids, severe interstitial cystitis, inflammatory bowel disease) that have not been adequately addressed or where these conditions are considered the primary source of pain.\n* Known Allergy: Documented severe allergy to contrast media or any components of the embolizing materials that cannot be managed.\n* Inability to Consent or Cooperate: Patients with cognitive impairment, psychological instability, or uncooperative behavior that would prevent informed consent or adherence to study procedures and follow-up.","18 Years","50 Years",{"count":52,"type":22},100,[25],"Transcatheter Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Pelvic Congestion Syndrome Secondary to May-Thurner Syndrome.\n\nThis study aims to prospectively evaluate the short-term clinical outcomes and the incidence of post-embolization stenting for residual symptoms.",[28],"NOT_YET_RECRUITING","2026-03-13",{"date":59,"type":33},"2026-03-16",{"date":61,"type":22},"2026-03-01",{"date":63,"type":22},"2027-12-01",{"name":65,"class":40},"Mark Magdy Zekry",{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":4,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":17,"minAge":73,"maxAge":50,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":76,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":41},"100559143","glue-embolization-vs-conservative-treatment-for-pelvic-congestion-syndrome-100559143","NCT06560294","Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome","Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial","Inclusion Criteria:\n\n* Women aged from 30 to 50 years.\n* Complaining from pelvic congestion syndrome.\n\nExclusion Criteria:\n\n* Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.\n* Patients who are treated with opiates to reduce pelvic pain in the period before the study.\n* Patient with history of contrast allergy\n* Patient with renal impairment\n* Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst\n* Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.","30 Years",{"count":75,"type":22},40,[25],"The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.",[79,28],"Glue Embolization","2025-08-18",{"date":82,"type":33},"2025-08-19",{"date":84,"type":33},"2024-08-17",{"date":86,"type":22},"2025-10-01",{"name":88,"class":40},"Tanta University"]